Immune Function and Recurrent Pregnancy Loss

Abstract

Recurrent pregnancy loss (RPL), defined as two or more consecutive miscarriages, is attributable to multiple causes. However, in 50% of cases no known cause is found. Although endometritis is a known cause of miscarriage, other inflammatory processes may play a role in idiopathic, recurrent loss. The fetoplacental unit evades rejection by the maternal immune system by poorly understood mechanisms. Despite this seemingly immune-privileged state for the fetus, human implantation requires inflammatory mediators for attachment and implantation. This review describes how the immune system must simultaneously permit and restrict trophoblastic invasion for healthy implantation and maintenance of pregnancy. Included in this review is a detailed description of the immune milieu in the decidua and abnormalities that are associated with RPL. Finally, autoimmune states associated with RPL and their treatment in an obstetrical setting are reviewed.

Keywords

recurrent pregnancy loss - inflammation - implantation - immune tolerance

• References

• 1 Boklage CE. Survival probability of human conceptions from fertilization to term. Int J Fertil 1990; 35 (2) 75, 79–80, 81–94
• 2 Wilcox AJ, Weinberg CR, O'Connor JF , et al. Incidence of early loss of pregnancy. N Engl J Med 1988; 319 (4) 189-194
• 3 Practice Committee of American Society for Reproductive Medicine. Definitions of infertility and recurrent pregnancy loss: a committee opinion. Fertil Steril 2013; 99 (1) 63
• 4 Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril 2012; 98 (5) 1103-1111
• 5 McQueen DB, Bernardi LA, Stephenson MD. Chronic endometritis in women with recurrent early pregnancy loss and/or fetal demise. Fertil Steril 2014; 101 (4) 1026-1030
• 6 Liddell HS, Pattison NS, Zanderigo A. Recurrent miscarriage—outcome after supportive care in early pregnancy. Aust N Z J Obstet Gynaecol 1991; 31 (4) 320-322
• 7 Musters AM, Taminiau-Bloem EF, van den Boogaard E, van der Veen F, Goddijn M. Supportive care for women with unexplained recurrent miscarriage: patients' perspectives. Hum Reprod 2011; 26 (4) 873-877
• 8 Whitley KA, Ural SH. Treatment modalities in recurrent miscarriages without diagnosis. Semin Reprod Med 2014; 32 (4) 319-322
• 9 Singh M, Chaudhry P, Asselin E. Bridging endometrial receptivity and implantation: network of hormones, cytokines, and growth factors. J Endocrinol 2011; 210 (1) 5-14
• 10 Lockwood CJ, Krikun G, Rahman M, Caze R, Buchwalder L, Schatz F. The role of decidualization in regulating endometrial hemostasis during the menstrual cycle, gestation, and in pathological states. Semin Thromb Hemost 2007; 33 (1) 111-117
• 11 Lessey BA, Young SL. Homeostasis imbalance in the endometrium of women with implantation defects: the role of estrogen and progesterone. Semin Reprod Med 2014; 32 (5) 365-375
• 12 Nikas G, Aghajanova L. Endometrial pinopodes: some more understanding on human implantation?. Reprod Biomed Online 2002; 4 (Suppl. 03) 18-23
• 13 Someya M, Kojima T, Ogawa M , et al. Regulation of tight junctions by sex hormones in normal human endometrial epithelial cells and uterus cancer cell line Sawano. Cell Tissue Res 2013; 354 (2) 481-494
• 14 Murphy CR, Rogers PA, Hosie MJ, Leeton J, Beaton L. Tight junctions of human uterine epithelial cells change during the menstrual cycle: a morphometric study. Acta Anat (Basel) 1992; 144 (1) 36-38
• 15 Teles A, Zenclussen AC. How cells of the immune system prepare the endometrium for implantation. Semin Reprod Med 2014; 32 (5) 358-364
• 16 Haller-Kikkatalo K, Altmäe S, Tagoma A, Uibo R, Salumets A. Autoimmune activation toward embryo implantation is rare in immune-privileged human endometrium. Semin Reprod Med 2014; 32 (5) 376-384
• 17 Park DW, Yang KM. Hormonal regulation of uterine chemokines and immune cells. Clin Exp Reprod Med 2011; 38 (4) 179-185
• 18 Straub RH. The complex role of estrogens in inflammation. Endocr Rev 2007; 28 (5) 521-574
• 19 Olsen NJ, Kovacs WJ. Gonadal steroids and immunity. Endocr Rev 1996; 17 (4) 369-384
• 20 Kim JJ, Taylor HS, Lu Z , et al. Altered expression of HOXA10 in endometriosis: potential role in decidualization. Mol Hum Reprod 2007; 13 (5) 323-332
• 21 Taylor HS, Bagot C, Kardana A, Olive D, Arici A. HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod 1999; 14 (5) 1328-1331
• 22 Lessey BA, Castelbaum AJ, Sawin SW , et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994; 79 (2) 643-649
• 23 Calleja-Agius J, Jauniaux E, Pizzey AR, Muttukrishna S. Investigation of systemic inflammatory response in first trimester pregnancy failure. Hum Reprod 2012; 27 (2) 349-357
• 24 Calleja-Agius J, Jauniaux E, Muttukrishna S. Placental villous expression of TNF α and IL-10 and effect of oxygen tension in euploid early pregnancy failure. Am J Reprod Immunol 2012; 67 (6) 515-525
• 25 Christiansen OB. Reproductive immunology. Mol Immunol 2013; 55 (1) 8-15
• 26 Bansal AS. Joining the immunological dots in recurrent miscarriage. Am J Reprod Immunol 2010; 64 (5) 307-315
• 27 Seshadri S, Sunkara SK. Natural killer cells in female infertility and recurrent miscarriage: a systematic review and meta-analysis. Hum Reprod Update 2014; 20 (3) 429-438
• 28 Park DW, Lee HJ, Park CW, Hong SR, Kwak-Kim J, Yang KM. Peripheral blood NK cells reflect changes in decidual NK cells in women with recurrent miscarriages. Am J Reprod Immunol 2010; 63 (2) 173-180
• 29 Thum MY, Bhaskaran S, Abdalla HI , et al. An increase in the absolute count of CD56dimCD16+CD69+ NK cells in the peripheral blood is associated with a poorer IVF treatment and pregnancy outcome. Hum Reprod 2004; 19 (10) 2395-2400
• 30 Polgar K, Hill JA. Identification of the white blood cell populations responsible for Th1 immunity to trophoblast and the timing of the response in women with recurrent pregnancy loss. Gynecol Obstet Invest 2002; 53 (1) 59-64
• 31 Wilkens J, Male V, Ghazal P , et al. Uterine NK cells regulate endometrial bleeding in women and are suppressed by the progesterone receptor modulator asoprisnil. J Immunol 2013; 191 (5) 2226-2235
• 32 Jensen F, Woudwyk M, Teles A , et al. Estradiol and progesterone regulate the migration of mast cells from the periphery to the uterus and induce their maturation and degranulation. PLoS ONE 2010; 5 (12) e14409
• 33 Woidacki K, Jensen F, Zenclussen AC. Mast cells as novel mediators of reproductive processes. Front Immunol 2013; 4: 29
• 34 Woidacki K, Popovic M, Metz M , et al. Mast cells rescue implantation defects caused by c-kit deficiency. Cell Death Dis 2013; 4: e462
• 35 Drudy L, Sheppard B, Bonnar J. Mast cells in the normal uterus and in dysfunctional uterine bleeding. Eur J Obstet Gynecol Reprod Biol 1991; 39 (3) 193-201
• 36 Eidukaite A, Tamosiunas V. Endometrial and peritoneal macrophages: expression of activation and adhesion molecules. Am J Reprod Immunol 2004; 52 (2) 113-117
• 37 Tachi C, Tachi S. Macrophages and implantation. Ann N Y Acad Sci 1986; 476: 158-182
• 38 Miller L, Hunt JS. Sex steroid hormones and macrophage function. Life Sci 1996; 59 (1) 1-14
• 39 Houser BL, Tilburgs T, Hill J, Nicotra ML, Strominger JL. Two unique human decidual macrophage populations. J Immunol 2011; 186 (4) 2633-2642
• 40 Lin YJ, Lai MD, Lei HY, Wing LY. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology 2006; 147 (3) 1278-1286
• 41 Strzemienski PJ, Dyer RM, Kenney RM. Effect of estradiol and progesterone on antistaphylococcal activity of neutrophils from ovariectomized mares. Am J Vet Res 1987; 48 (11) 1638-1641
• 42 Strzemienski PJ, Dyer RM, Sertich PL, Garcia MC, Kenney RM. Bactericidal activity of peripheral blood neutrophils during the oestrous cycle and early pregnancy in the mare. J Reprod Fertil 1987; 80 (1) 289-293
• 43 Wiesenfeld HC, Heine RP, Krohn MA , et al. Association between elevated neutrophil defensin levels and endometritis. J Infect Dis 2002; 186 (6) 792-797
• 44 Amsalem H, Kwan M, Hazan A , et al. Identification of a novel neutrophil population: proangiogenic granulocytes in second-trimester human decidua. J Immunol 2014; 193 (6) 3070-3079
• 45 Kasius JC, Fatemi HM, Bourgain C , et al. The impact of chronic endometritis on reproductive outcome. Fertil Steril 2011; 96 (6) 1451-1456
• 46 Alijotas-Reig J, Llurba E, Gris JM. Potentiating maternal immune tolerance in pregnancy: a new challenging role for regulatory T cells. Placenta 2014; 35 (4) 241-248
• 47 La Rocca C, Carbone F, Longobardi S, Matarese G. The immunology of pregnancy: regulatory T cells control maternal immune tolerance toward the fetus. Immunol Lett 2014; 162 (1, Pt A): 41-48
• 48 Tilburgs T, Scherjon SA, van der Mast BJ , et al. Fetal-maternal HLA-C mismatch is associated with decidual T cell activation and induction of functional T regulatory cells. J Reprod Immunol 2009; 82 (2) 148-157
• 49 Würfel W. Treatment with granulocyte colony-stimulating factor in patients with repetitive implantation failures and/or recurrent spontaneous abortions. J Reprod Immunol 2015; 108: 123-135
• 50 Rahmati M, Petitbarat M, Dubanchet S, Bensussan A, Chaouat G, Ledee N. Granulocyte-Colony Stimulating Factor related pathways tested on an endometrial ex-vivo model. PLoS ONE 2014; 9 (9) e102286
• 51 Bansal RR, Mackay CR, Moser B, Eberl M. IL-21 enhances the potential of human γδ T cells to provide B-cell help. Eur J Immunol 2012; 42 (1) 110-119
• 52 Szekeres-Bartho J, Barakonyi A, Miko E, Polgar B, Palkovics T. The role of gamma/delta T cells in the feto-maternal relationship. Semin Immunol 2001; 13 (4) 229-233
• 53 Mincheva-Nilsson L. Pregnancy and gamma/delta T cells: taking on the hard questions. Reprod Biol Endocrinol 2003; 1: 120
• 54 Krieg SA, Fan X, Hong Y , et al. Global alteration in gene expression profiles of deciduas from women with idiopathic recurrent pregnancy loss. Mol Hum Reprod 2012; 18 (9) 442-450
• 55 Wang WJ, Liu FJ, Qu HM , et al. Regulation of the expression of Th17 cells and regulatory T cells by IL-27 in patients with unexplained early recurrent miscarriage. J Reprod Immunol 2013; 99 (1-2) 39-45
• 56 Bansal AS, Bajardeen B, Thum MY. The basis and value of currently used immunomodulatory therapies in recurrent miscarriage. J Reprod Immunol 2012; 93 (1) 41-51
• 57 Szereday L, Miko E, Meggyes M , et al. Commitment of decidual haematopoietic progenitor cells in first trimester pregnancy. Am J Reprod Immunol 2012; 67 (1) 9-16
• 58 Saifi B, Rezaee SA, Tajik N , et al. Th17 cells and related cytokines in unexplained recurrent spontaneous miscarriage at the implantation window. Reprod Biomed Online 2014; 29 (4) 481-489
• 59 Stuart LM, Takahashi K, Shi L, Savill J, Ezekowitz RA. Mannose-binding lectin-deficient mice display defective apoptotic cell clearance but no autoimmune phenotype. J Immunol 2005; 174 (6) 3220-3226
• 60 Ogden CA, deCathelineau A, Hoffmann PR , et al. C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med 2001; 194 (6) 781-795
• 61 Kilpatrick DC, Bevan BH, Liston WA. Association between mannan binding protein deficiency and recurrent miscarriage. Hum Reprod 1995; 10 (9) 2501-2505
• 62 Christiansen OB, Nielsen HS, Lund M, Steffensen R, Varming K. Mannose-binding lectin-2 genotypes and recurrent late pregnancy losses. Hum Reprod 2009; 24 (2) 291-299
• 63 Hiby SE, Apps R, Sharkey AM , et al. Maternal activating KIRs protect against human reproductive failure mediated by fetal HLA-C2. J Clin Invest 2010; 120 (11) 4102-4110
• 64 Christiansen OB, Kolte AM, Dahl M , et al. Maternal homozygocity for a 14 base pair insertion in exon 8 of the HLA-G gene and carriage of HLA class II alleles restricting HY immunity predispose to unexplained secondary recurrent miscarriage and low birth weight in children born to these patients. Hum Immunol 2012; 73 (7) 699-705
• 65 Moffett A, Hiby SE, Sharkey AM. The role of the maternal immune system in the regulation of human birthweight. Philos Trans R Soc Lond B Biol Sci 2015; 370 (1663) 20140071
• 66 Christiansen OB, Steffensen R, Nielsen HS. The impact of anti-HY responses on outcome in current and subsequent pregnancies of patients with recurrent pregnancy losses. J Reprod Immunol 2010; 85 (1) 9-14
• 67 Nielsen HS, Witvliet MD, Steffensen R , et al. The presence of HLA-antibodies in recurrent miscarriage patients is associated with a reduced chance of a live birth. J Reprod Immunol 2010; 87 (1-2) 67-73
• 68 Christiansen OB, Steffensen R, Nielsen HS, Varming K. Multifactorial etiology of recurrent miscarriage and its scientific and clinical implications. Gynecol Obstet Invest 2008; 66 (4) 257-267
• 69 Ticconi C, Rotondi F, Veglia M , et al. Antinuclear autoantibodies in women with recurrent pregnancy loss. Am J Reprod Immunol 2010; 64 (6) 384-392
• 70 Meroni PL, Borghi MO, Raschi E, Tedesco F. Pathogenesis of antiphospholipid syndrome: understanding the antibodies. Nat Rev Rheumatol 2011; 7 (6) 330-339
• 71 Qureshi F, Yang Y, Jaques SM , et al. Anti-DNA antibodies cross-reacting with laminin inhibit trophoblast attachment and migration: implications for recurrent pregnancy loss in SLE patients. Am J Reprod Immunol 2000; 44 (3) 136-142
• 72 Petri M, Allbritton J. Fetal outcome of lupus pregnancy: a retrospective case-control study of the Hopkins Lupus Cohort. J Rheumatol 1993; 20 (4) 650-656
• 73 Hardy CJ, Palmer BP, Morton SJ, Muir KR, Powell RJ. Pregnancy outcome and family size in systemic lupus erythematosus: a case-control study. Rheumatology (Oxford) 1999; 38 (6) 559-563
• 74 Naganuma M, Kunisaki R, Yoshimura N , et al. Conception and pregnancy outcome in women with inflammatory bowel disease: A multicentre study from Japan. J Crohn's Colitis 2011; 5 (4) 317-323
• 75 Miyakis S, Lockshin MD, Atsumi T , et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost 2006; 4 (2) 295-306
• 76 Ernest JM, Marshburn PB, Kutteh WH. Obstetric antiphospholipid syndrome: an update on pathophysiology and management. Semin Reprod Med 2011; 29 (6) 522-539
• 77 Committee on Practice Bulletins—Obstetrics, American College of Obstetricians and Gynecologists. Practice Bulletin No. 132: Antiphospholipid syndrome. Obstet Gynecol 2012; 120 (6) 1514-1521
• 78 de Jesus GR, Agmon-Levin N, Andrade CA , et al. 14th International Congress on Antiphospholipid Antibodies Task Force report on obstetric antiphospholipid syndrome. Autoimmun Rev 2014; 13 (8) 795-813
• 79 Di Simone N, Meroni PL, de Papa N , et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000; 43 (1) 140-150
• 80 Meroni PL , et al. Human beta2-GPI binds to trophoblast through its fifth domain affecting human chorionic gonadotrophin release. Arthritis Rheum 2000; 43 (9) S306-S306
• 81 Di Simone N, Di Nicuolo F, D'Ippolito S , et al. Antiphospholipid antibodies affect human endometrial angiogenesis. Biol Reprod 2010; 83 (2) 212-219
• 82 Stagnaro-Green A, Roman SH, Cobin RH, el-Harazy E, Alvarez-Marfany M, Davies TF. Detection of at-risk pregnancy by means of highly sensitive assays for thyroid autoantibodies. JAMA 1990; 264 (11) 1422-1425
• 83 Smith ML, Schust DJ. Endocrinology and recurrent early pregnancy loss. Semin Reprod Med 2011; 29 (6) 482-490
• 84 Imaizumi M, Pritsker A, Kita M, Ahmad L, Unger P, Davies T. Pregnancy and murine thyroiditis: thyroglobulin immunization leads to fetal loss in specific allogeneic pregnancies. Endocrinology 2001; 142 (2) 823-829
• 85 Imaizumi M, Pritsker A, Kita M, Ahmad L, Unger P, Davies TF. Non-MHC driven exacerbation of experimental thyroiditis in the postpartum period. Autoimmunity 2001; 34 (2) 95-105
• 86 Iijima T, Tada H, Hidaka Y, Mitsuda N, Murata Y, Amino N. Effects of autoantibodies on the course of pregnancy and fetal growth. Obstet Gynecol 1997; 90 (3) 364-369
• 87 Kutteh WH, Schoolcraft WB, Scott Jr RT. Antithyroid antibodies do not affect pregnancy outcome in women undergoing assisted reproduction. Hum Reprod 1999; 14 (11) 2886-2890
• 88 Kutteh WH, Yetman DL, Carr AC, Beck LA, Scott Jr RT. Increased prevalence of antithyroid antibodies identified in women with recurrent pregnancy loss but not in women undergoing assisted reproduction. Fertil Steril 1999; 71 (5) 843-848
• 89 Negro R, Formoso G, Mangieri T, Pezzarossa A, Dazzi D, Hassan H. Levothyroxine treatment in euthyroid pregnant women with autoimmune thyroid disease: effects on obstetrical complications. J Clin Endocrinol Metab 2006; 91 (7) 2587-2591
• 90 Glinoer D. Thyroid immunity, thyroid dysfunction, and the risk of miscarriage: à propos article by Vaquero et al. Mild thyroid abnormalities and recurrent spontaneous abortion: diagnostic and therapeutical approach. Am J Reprod Immunol 2000; 43 (4) 202-203
• 91 Krassas GE, Poppe K, Glinoer D. Thyroid function and human reproductive health. Endocr Rev 2010; 31 (5) 702-755
• 92 Reid SM, Middleton P, Cossich MC, Crowther CA. Interventions for clinical and subclinical hypothyroidism in pregnancy. Cochrane Database Syst Rev 2010; (7) CD007752
• 93 Pengo V, Tripodi A, Reber G , et al; Subcommittee on Lupus Anticoagulant/Antiphospholipid Antibody of the Scientific and Standardisation Committee of the International Society on Thrombosis and Haemostasis. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost 2009; 7 (10) 1737-1740
• 94 Prins JR, Kieffer TE, Scherjon SA. Immunomodulators to treat recurrent miscarriage. Eur J Obstet Gynecol Reprod Biol 2014; 181: 334-337